Validating Process Controls for Enteric-Coated Tablet Manufacturing

Validating Process Controls for Enteric-Coated Tablet Manufacturing

Published on 28/12/2025

Validating Process Controls for Enteric-Coated Tablet Manufacturing

Introduction:

In the pharmaceutical industry, enteric-coated tablets are pivotal in ensuring that active ingredients are released in the intestine rather than the stomach. This is crucial for drugs that degrade in acidic environments or can irritate the gastric lining. Validating process controls in the manufacturing of enteric-coated tablets is essential to assure quality, efficacy, and patient safety. This comprehensive guide delves into the importance of process validation, challenges faced, and the best practices for ensuring the production of high-quality enteric-coated tablets.

Challenges and Issues:

  • Ensuring uniform coating application to prevent variability in drug release.
  • Managing moisture content which can affect the integrity of the enteric coating.
  • Preventing tablet core degradation during the coating process.
  • Achieving optimal adhesion of the coating to the tablet core.
  • Maintaining stability of the active pharmaceutical ingredient (API) throughout the process.
Pharma Tip:  Preventing Tablet Damage During Drop Testing of Blister Packs

Step-by-Step Troubleshooting Guide:

  1. Pre-Validation Assessment: Before initiating the coating process, conduct a thorough assessment of raw materials, including the API and excipients. Ensure they meet predefined quality specifications.
  2. Coating Solution Preparation: Validate the preparation process of the enteric coating solution. Check for consistency in viscosity and pH levels to ensure uniform application.
  3. Environmental Controls: Monitor and control environmental conditions such as humidity
and temperature in the coating area to prevent moisture-related issues.
  • Equipment Calibration and Maintenance: Regularly calibrate and maintain coating equipment to ensure precise application and prevent mechanical failures.
  • In-Process Monitoring: Implement real-time monitoring of critical process parameters such as spray rate, air pressure, and drum speed to ensure consistent coating.
  • Coating Thickness Measurement: Use techniques such as micrometers or non-destructive testing methods to measure coating thickness and ensure it meets specifications.
  • Adhesion Testing: Conduct adhesion tests to confirm that the coating adheres properly to the tablet core, preventing delamination during storage or transport.
  • Dissolution Testing: Perform dissolution testing to verify that the enteric-coated tablets release the API under the intended pH conditions.

    • Regulatory Guidelines:

    The USFDA provides comprehensive guidelines on process validation, emphasizing a lifecycle approach that includes design, qualification, and continued process verification. The International Council for Harmonisation (ICH) Q8 and Q9 also offer guidelines on pharmaceutical development and quality risk management. Adhering to these standards is crucial for compliance and ensuring product quality in enteric-coated tablet manufacturing.

    Conclusion:

    Validating process controls in the manufacturing of enteric-coated tablets is a complex but necessary endeavor to ensure product efficacy and safety. By addressing challenges such as coating uniformity, moisture control, and equipment calibration, manufacturers can optimize their processes and adhere to regulatory standards. Continuous monitoring and adherence to best practices ensure that enteric-coated tablets perform as intended, ultimately enhancing patient outcomes and maintaining compliance with regulatory requirements.

    Pharma Tip:  Root Cause Analysis for Failures in QA Monitoring for Enteric Tablets

    Also Read